Renovaro Biosciences Shares Outstanding vs. Beta
| RENB Stock | 0.69 0.08 12.95% |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Gross Profit Margin | 0.19 | 0.21 |
|
|
For Renovaro Biosciences profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Renovaro Biosciences to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Renovaro Biosciences utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Renovaro Biosciences's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Renovaro Biosciences over time as well as its relative position and ranking within its peers.
Renovaro |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Renovaro Biosciences. If investors know Renovaro will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Renovaro Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.98) | Return On Assets (0.15) | Return On Equity (0.90) |
The market value of Renovaro Biosciences is measured differently than its book value, which is the value of Renovaro that is recorded on the company's balance sheet. Investors also form their own opinion of Renovaro Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Renovaro Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Renovaro Biosciences' market value can be influenced by many factors that don't directly affect Renovaro Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Renovaro Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Renovaro Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Renovaro Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Renovaro Biosciences Beta vs. Shares Outstanding Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Renovaro Biosciences's current stock value. Our valuation model uses many indicators to compare Renovaro Biosciences value to that of its competitors to determine the firm's financial worth. Renovaro Biosciences is currently regarded as top stock in shares outstanding category among its peers. It also is currently regarded as top stock in beta category among its peers . The ratio of Shares Outstanding to Beta for Renovaro Biosciences is about 292,296,486 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Renovaro Biosciences' earnings, one of the primary drivers of an investment's value.Renovaro Beta vs. Shares Outstanding
Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Renovaro Biosciences |
| = | 158.72 M |
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
Renovaro Biosciences |
| = | 0.54 |
In a nutshell, Beta is a measure of individual stock risk relative to the overall volatility of the stock market. and is calculated based on very sound finance theory - Capital Assets Pricing Model (CAPM).However, since Beta is calculated based on historical price movements it may not predict how a firm's stock is going to perform in the future.
Renovaro Beta Comparison
Renovaro Biosciences is currently under evaluation in beta category among its peers.
Beta Analysis
As returns on the market increase, Renovaro Biosciences' returns are expected to increase less than the market. However, during the bear market, the loss of holding Renovaro Biosciences is expected to be smaller as well.
Renovaro Biosciences Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Renovaro Biosciences, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Renovaro Biosciences will eventually generate negative long term returns. The profitability progress is the general direction of Renovaro Biosciences' change in net profit over the period of time. It can combine multiple indicators of Renovaro Biosciences, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | -170.8 K | -162.3 K | |
| Operating Income | -81.6 M | -77.6 M | |
| Income Before Tax | -80.7 M | -76.6 M | |
| Net Loss | -80.7 M | -76.6 M | |
| Total Other Income Expense Net | 989.1 K | 1 M | |
| Interest Income | 103.6 K | 72.3 K | |
| Net Loss | -35.7 M | -37.5 M | |
| Non Operating Income Net Other | 550.5 K | 578 K | |
| Net Loss | -35.7 M | -37.5 M | |
| Income Tax Expense | 1.00 | 1.05 | |
| Net Interest Income | -636.3 K | -604.5 K | |
| Change To Netincome | 26.6 M | 16.6 M | |
| Net Loss | (0.84) | (0.88) | |
| Income Quality | 0.14 | 0.13 | |
| Net Income Per E B T | 0.90 | 0.77 |
Renovaro Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Renovaro Biosciences. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Renovaro Biosciences position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Renovaro Biosciences' important profitability drivers and their relationship over time.
Use Renovaro Biosciences in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Renovaro Biosciences position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Renovaro Biosciences will appreciate offsetting losses from the drop in the long position's value.Renovaro Biosciences Pair Trading
Renovaro Biosciences Pair Trading Analysis
The ability to find closely correlated positions to Renovaro Biosciences could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Renovaro Biosciences when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Renovaro Biosciences - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Renovaro Biosciences to buy it.
The correlation of Renovaro Biosciences is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Renovaro Biosciences moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Renovaro Biosciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Renovaro Biosciences can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Renovaro Biosciences position
In addition to having Renovaro Biosciences in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Commodities Funds Thematic Idea Now
Commodities Funds
Funds or Etfs investing in commodities such as oil, gold, corn, soy, and agricultural goods. The Commodities Funds theme has 40 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Commodities Funds Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Your Equity Center. For information on how to trade Renovaro Stock refer to our How to Trade Renovaro Stock guide.You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
To fully project Renovaro Biosciences' future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Renovaro Biosciences at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Renovaro Biosciences' income statement, its balance sheet, and the statement of cash flows.